BGC201531 (AP-1531) is a selective EP4 receptor antagonist developed for acute migraine research. It has demonstrated efficacy in preclinical models of migraine pain, supporting its investigation in both in vitro receptor studies and in vivo animal experiments related to inflammation and nociception.
Molecular Weight:
496.58
Purity:
99.33% (May vary between batches)
CAS Number:
[1186532-61-5]
Formula:
C26H28N2O6S
Target:
PKA,Prostaglandin Receptor
* VAT and and shipping costs not included. Errors and price changes excepted